# Gemstone BioTherapeutics, LLC — Form D

Gemstone BioTherapeutics, LLC of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2015-06-17. The offering totals $1.6M, of which $1.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2015-06-17
- Form: D
- Accession: 0001014100-15-000017
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.6M
- Amount sold: $1.6M
- Minimum investment: $100K
- Investors: 3
- Date of first sale: 2015-06-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-242020

## Issuer

- Name: Gemstone BioTherapeutics, LLC
- CIK: 0001644667
- Entity type: Limited Liability Company
- Jurisdiction: MARYLAND
- Incorporated: 2013
- Address: 180 W. OSTEND STREET, BALTIMORE, MD, 21230
- Phone: 443-873-7010

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Sharon Gerecht | Director | Baltimore, MD |
| Geoff MacKay | Director | Toronto, A6 |
| George Davis | Director | Albany, NY |
| George Davis | Executive Officer | Albany, NY |
| George Davis | Promoter | Albany, NY |
| XIN HUANG | Director | Watertown, MA |
| David Oros | Director | Bethesda, MD |
| David Oros | Promoter | Bethesda, MD |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2016-10-27](https://search.stillhousedata.com/formd/0001014100-16-000052) | D | $3.5M | $700K |

## More

- [CIK 1644667 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1644667&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001014100-15-000017.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.